- active not recruitingPHASE4
CINC424A2X01B Rollover Protocol
This study is for patients already taking ruxolitinib, or ruxolitinib with panobinostat, in a previous trial, and who are still benefiting. It lets them continue their treatment and helps researchers learn more about the long-term safety of these medications.
Australia · Belgium · Bulgaria - not yet recruitingPHASE2, PHASE3
Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL
This study looks at new ways to make stem cell transplants safer and more effective for children and young people with a type of blood cancer called ALL. Researchers want to reduce serious side effects and improve long-term health for these patients.
Austria · Czechia · Denmark